Ciprofloxacin HCl tablet
Formulation (FDF) · tablet · 250mg 500mg
Formulation (FDF)Confidentiality：Public
- INN / Generic Name
- Ciprofloxacin HCl tablet
- Dosage Form
- tablet
- Strength
- 250mg 500mg
- Therapy Area
- Infectious Diseases
- Indication
- Bacterial infection; Urinary tract infection; Respiratory tract infection; Skin and soft tissue infection; Gastrointestinal infection
- Current Status
- Official FDF licensing catalog (UB721)
- GMP Certification
- US - FDA; UK - MHRA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- Registered (market rights transferable / DCP·NP per market)
- MOQ
- On request
- Lead Time
- On request
- Price Range
- On request
HS Code
3004.903 customs bills on file
Registrable Markets
United StatesChina
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price